This week’s newsletter covers the latest research on cannabinoids and psychedelics, including CBD prevalence in the US, cannabis for arthritis and pain relief, the therapeutic promise of minor cannabinoids like CBN and CBG, and new findings on psychedelics and heart activity.
Research Round-Up
Prevalence of CBD Use and Correlates in US Adults (Drug and Alcohol Dependence Reports)
A study using data from the 2022 U.S. National Survey on Drug Use and Health found that 20.6% of adults reported CBD use in the past year, with 63% also using cannabis.
Patients with Rheumatoid and Psoriatic Arthritis Benefit from Cannabis (Cureus)
A study published in Cureus found that cannabis use significantly alleviated symptoms for patients with rheumatoid and psoriatic arthritis, highlighting its potential as an adjunct therapy.
Read more
View more in Endocannabinoid System
Longitudinal Study: Changes in Pain & Mental Health Symptoms with Prescribed Medical Cannabis Use (Journal of Pain & Palliative Care Pharmacotherapy)
A study in the Journal of Pain & Palliative Care Pharmacotherapy reported significant reductions in pain and improvements in mental health symptoms among patients using prescribed medical cannabis over time.
The Therapeutic Potential of Minor Cannabinoids in Psychiatric Disorders (PubMed)
A review in PubMed highlights emerging evidence for minor cannabinoids like CBG and CBN in managing anxiety, depression, and PTSD, though further studies are needed to understand their mechanisms.
Read more
View more in Endocannabinoid System
CBN Influences Sleep Architecture (PubMed)
A PubMed study examined how cannabinol (CBN) affects sleep patterns, showing its potential to improve sleep quality and duration. The findings may suggest CBN could serve as a novel treatment for sleep disorders.
Scientists Uncover Link Between Psychedelic Experiences and Heart Activity (PsyPost)
A study in PsyPost reveals how psychedelic-induced experiences correlate with changes in heart activity, potentially providing insights into their therapeutic effects on emotional and cognitive processes.
Read more
View more in Psychedelics
A heartfelt thank you to the CBD brands whose generous support makes it possible for Project CBD to bring you the latest in plant medicine research every week — we couldn’t do this work without you.
